Supplementation with resveratrol as Polygonum cuspidatum Sieb. et Zucc. extract induces changes in the excretion of urinary markers associated to aging in rats

Fitoterapia

Volumn 129, Issue , 2018, Pages 154-161

  Peron, Gregorio ^a   Dall'Acqua, Stefano ^a   Sut, Stefania ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Aging; Metabolomics; Resveratrol; UPLC MS; Urine

Indexed keywords

3 HYDROXYSEBACIC ACID; 4,6 DIHYDROXYQUINOLINE; AMIDE; BIOLOGICAL MARKER; GLYCINE DERIVATIVE; N METHYL 2 PYRIDONE 5 CARBOXAMIDE; PHENYLACETYLGLYCINE; POLYGONUM CUSPIDATUM EXTRACT; QUINOLINE DERIVATIVE; RESVERATROL; SEBACIC ACID; UNCLASSIFIED DRUG; GLYCINE; N-METHYL-2-PYRIDONE-5-CARBOXAMIDE; PLANT EXTRACT; PYRIDONE DERIVATIVE; STILBENE DERIVATIVE;

AGING; ARTICLE; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; METABOLOMICS; POLYGONUM CUSPIDATUM; PRIORITY JOURNAL; SUPPLEMENTATION; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; URINARY EXCRETION; URINE LEVEL; URINE VOLUME; ANALOGS AND DERIVATIVES; ANIMAL; CHEMISTRY; DRUG EFFECT; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; RAT; SPRAGUE DAWLEY RAT; URINE;

AGING; ANIMALS; BIOMARKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FALLOPIA JAPONICA; FEMALE; GLYCINE; MALE; MASS SPECTROMETRY; METABOLOMICS; PLANT EXTRACTS; PYRIDONES; RATS; RATS, SPRAGUE-DAWLEY; STILBENES;

EID: 85049311036     PISSN: 0367326X     EISSN: 18736971     Source Type: Journal    
DOI: 10.1016/j.fitote.2018.06.022     Document Type: Article

References (41)

1. Espín, J.C., García-Conesa, M.T., Tomás-Barberán, F.A., Nutraceuticals: facts and fiction. Phytochemistry 68 (2007), 2986–3008.
2. Sut, S., Baldan, V., Faggian, M., Peron, G., Dall'Acqua, S., Nutraceuticals, a new challenge for medicinal chemistry. Curr. Med. Chem. 23 (2016), 1–26.
3. Fontana, L., Klein, S., Aging, adiposity, and calorie restriction. J. Am. Med. Assoc. 297 (2007), 986–994.
4. Pham-Huy, L.A., He, H., Pham-Huy, C., Free Radicals Antioxidants in disease and health. Int. J. Biomed. Sci. 4 (2008), 89–96.
5. Rietjens, I.M.C.M., Boersma, M.G., Haan, L.D., Spenkelink, B., Awad, H.M., Cnubben, N.H.P., Van Zanden, J.J., Woude, H.V.D., Alink, G.M., Koeman, J.H., The pro-oxidant chemistry of the natural antioxidants vitamin C, vitamin E, carotenoids and flavonoids. Environ. Toxicol. Pharmacol. 11 (2002), 321–333.
6. Jasinski, M., Jasinska, L., Ogrodowczyk, M., Resveratrol in prostate diseases - a short review. Cent. Eur. J. Urol. 66 (2013), 144–149.
7. Athar, M., Back, J.H., Tang, X., Kim, K.H., Kopelovich, L., Bickers, D.R., Kim, A.L., Resveratrol: a review of preclinical studies for human cancer prevention. Toxicol. Appl. Pharmacol. 224 (2007), 274–283.
8. Baur, J.A., Sinclair, D.A., Therapeutic potential of resveratrol: the in vivo evidence. Nat. Rev. Drug Discov. 5 (2006), 493–506.
9. Frémont, L., Minireview: Biological effects of resveratrol. Life Sci. 66 (2000), 663–673.
10. Harikumar, K.B., Aggarwal, B.B., Resveratrol: a multitargeted agent for age-associated chronic diseases. Cell Cycle 7 (2008), 1020–1037.
11. Chen, W., Rezaizadehnajafi, L., Wink, M., Influence of resveratrol on oxidative stress resistance and life span in Caenorhabditis elegans. J. Pharm. Pharmacol. 65 (2013), 682–688.
12. Peron, G., Uddin, J., Stocchero, M., Mammi, S., Schievano, E., Dall'Acqua, S., Studying the effects of natural extracts with metabolomics: a longitudinal study on the supplementation of healthy rats with Polygonum cuspidatum Sieb. Et Zucc. J. Pharm. Biomed. Anal. 140 (2017), 62–70.
13. Peron, G., Pellizzaro, A., Brun, P., Schievano, E., Mammi, S., Sut, S., Castagliuolo, I., Dall'Acqua, S., Antiadhesive activity and metabolomics analysis of rat urine after cranberry (Vaccinium macrocarpon Aiton) administration. J. Agric. Food Chem. 65 (2017), 5657–5667.
14. Peron, G., Sut, S., Pellizzaro, A., Brun, P., Voinovich, D., Castagliuolo, I., Dall'Acqua, S., The antiadhesive activity of cranberry phytocomplex studied by metabolomics: intestinal PAC-A metabolites but not intact PAC-A are identified as markers in active urines against uropathogenic Escherichia coli. Fitoterapia 122 (2017), 67–75.
15. Peron, G., Santarossa, D., Voinovich, D., Dall'Acqua, S., Sut, S., Urine metabolomics shows an induction of fatty acids metabolism in healthy adult volunteers after supplementation with green coffee (Coffea robusta L.) bean extract. Phytomedicine 38 (2018), 74–83.
16. Guarente, L., Baur, J.A., Mai, A., Revelations into Resveratrol's mechanism. Nat. Med. 18 (2012), 500–501.
17. Park, S., Ahmad, F., Philp, A., Baar, K., Williams, T., Luo, H., Ke, H., Rehmann, H., Taussig, R., Brown, A.L. et al., Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell 148 (2012), 421–433.
18. Baur, J.A., Pearson, K.J., Price, N.L., Jamieson, H.A., Lerin, C., Kalra, A., Prabhu, V.V., Allard, J.S., Lopez-Lluch, G., Lewis, K. et al., Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444 (2006), 337–342.
19. Kaeberlein, M., McVey, M., Guarente, L., The SIR2/3/4 complex and SIR2 alone promote longevity in saccharomyces cerevisiae by two different mechanisms. Genes Dev. 13 (1999), 2570–2580.
20. Tissenbaum, H.A., Guarente, L., Increased dosage of a Sir-2 gene extends lifespan in Caenorhabditis Elegans. Nature 410 (2001), 227–230.
21. Rogina, B., Helfand, S.L., Sir2 mediates longevity in the fly through a pathway related to calorie restriction. Proc. Natl. Acad. Sci. U. S. A. 101 (2004), 15998–16003.
22. Qiao, Y., Sun, J., Xia, S., Tang, X., Shi, Y., Le, G., Effects of resveratrol on gut microbiota and fat storage in a mouse model with high-fat-induced obesity. Food Funct. 5 (2014), 1241–1249.
23. Stocchero, M., Paris, D., Post-transformation of PLS2 (ptPLS2) by orthogonal matrix: a new approach for generating predictive and orthogonal latent variables. J. Chemom. 30 (2016), 242–251.
24. Eḿlia Juan, M., Pilar Vinardell, M., Planas, J.M., The daily oral Administration of high doses of trans-resveratrol to rats for 28 days is not harmful. J. Nutr. 132 (2002), 257–260.
25. Tiwari, V., Chopra, K., Resveratrol prevents alcohol-induced cognitive deficits and brain damage by blocking inflammatory signaling and cell death Cascade in neonatal rat brain. J. Neurochem. 117 (2011), 678–690.
26. Pelantova, H., Bàrtovà S., Anýž J., Holubová M., Železná B., Maletínská L., Novák, D., Lacinová Z., Šulc, M., Haluzík, M. et al., Metabolomic profiling of urinary changes in mice with monosodium glutamate-induced obesity. Anal. Bioanal. Chem. 408 (2016), 567–578.
27. Moroni, F., Russi, P., Carla, V., Lombardi, G., Kynurenic acid is present in the rat brain and its content increases during development and aging processes. Neurosci. Lett. 94 (1988), 145–150.
28. Braidy, N., Guillemin, G.J., Mansour, H., Chan-Ling, T., Grant, R., Changes in kynurenine pathway metabolism in the brain, liver and kidney of aged female Wistar rats. FEBS J. 278 (2011), 4425–4434.
29. Gramsbergen, J.B.P., Schmidt, W., Turski, W.A., Schwarcz, R., Age-related changes in Kynurenic acid production in rat brain. Brain Res. 588 (1992), 1–5.
30. Lee, S.H., Park, S., Kim, H., Jung, B.H., Metabolomic approaches to the normal aging process. Metabolomics 10 (2014), 1268–1292.
31. Schnackenberg, L.K., Sun, J., Espandiari, P., Holland, R.D., Hanig, J., Beger, R.D., Metabonomics evaluations of age-related changes in the urinary compositions of male Sprague Dawley rats and effects of data normalization methods on statistical and quantitative analysis. BMC Bioinforma., 8, 2007.
32. Wang, D., Liu, W., Chen, G., A simple method for the isolation and purification of resveratrol from Polygonum cuspidatum. J. Pharmaceut. Anal. 3 (2013), 241–247.
33. Slominska, E.M., Rutkowski, P., Smolenski, R.T., Szutowicz, A., Rutkowski, B., Swierczynski, J., The age-related increase in N-Methyl-2-Pyridone-5-Carboxamide (NAD catabolite) in human plasma. Mol. Cell. Biochem. 267 (2004), 25–30.
34. Zhang, Y., Yan, S., Gao, X., Xiong, X., Dai, W., Liu, X., Li, L., Zhang, W., Mei, C., Analysis of urinary metabolic profile in aging rats undergoing caloric restriction. Aging Clin. Exp. Res. 24 (2012), 79–84.
35. Szkudelska, K., Szkudelski, T., Resveratrol, obesity and diabetes. Eur. J. Pharmacol. 635 (2010), 1–8.
36. Tserng, K., Jin, S., Metabolic origin of urinary 3-hydroxy dicarboxylic acids. Biochemistry 30 (1991), 2508–2514.
37. Campesan, S., Green, E.W., Breda, C., Sathyasaikumar, K.V., Muchowski, P.J., Schwarcz, R., Kyriacou, C.P., Giorgini, F., The kynurenine pathway modulates neurodegeneration in a Drosophila model of Huntington's disease. Curr. Biol. 21 (2011), 961–966.
38. Van Der Goot, A.T., Zhu, W., Vazquez-Manrique, R.P., Seinstra, R.I., Dettmer, K., Michels, H., Farina, F., Krijnen, J., Melki, R., Buijsman, R.C. et al., Delaying aging and the aging-associated decline in protein homeostasis by inhibition of tryptophan degradation. Proc. Natl. Acad. Sci. U. S. A. 109 (2012), 14912–14917.
39. Breda, C., Sathyasaikumar, K.V., Idrissi, S.S., Notarangelo, F.M., Estranero, J.G., Moore, G.G.L., Green, E.W., Kyriacou, C.P., Schwarcz, R., Giorgini, F., Tryptophan-2,3-dioxygenase (TDO) inhibition ameliorates neurodegeneration by modulation of kynurenine pathway metabolites. Proc. Natl. Acad. Sci. U. S. A. 113 (2016), 5435–5440.
40. Rebouche, C.J., Seim, H., Carnitine metabolism and its regulation in microorganisms and mammals. Annu. Rev. Nutr., 18, 1998.
41. Fouque, D., Holt, S., Guebre-Egziabher, F., Nakamura, K., Vianey-Saban, C., Hadj-Assa, A., Hoppel, C.L., Kopple, J.D., Relationship between serum carnitine, acylcarnitines, and renal function in patients with chronic renal disease. J. Renal Nutr. 16 (2006), 125–131.